Sam Altman said the one-person billion-dollar company was coming. The closest thing yet is a two-person weight-loss clinic. Matthew Gallagher, 41, launched Medvi - a direct-to-consumer telehealth service for GLP-1 medications - from his Los Angeles home in September 2024 with about $20,000. Fourteen months later, according to reporting in The New York Times and Forbes, it had recorded $401M in sales with one employee: his brother, Elliot.
The numbers
Per the reporting, customers grew from roughly 300 to more than 250,000; revenue runs at about $3M a day; the net margin is 16.2%; and a men's-health line added 50,000 customers in its first month. The company said it was on track for $1.8B in sales and to become a billion-dollar company in 2026. "It's not an AI company," Gallagher told reporters, "but I did it with AI. Growth was insane."
The stack
This is why the story belongs in Vibe Wire. Gallagher built the website with ChatGPT, Claude and Grok, added custom bots that handle tasks autonomously, tested AI voice tools from ElevenLabs to talk to customers, and used Midjourney and Runway for the site's and the ads' imagery and video. Licensed clinicians come through partners (CareValidate and OpenLoop); the drugs ship to the patient's door. Everything a 2019 startup would have hired forty people for is a subscription.
The interesting number is not $401M. It is two. Two people, a compounding ad machine and a stack of tools that cost less per month than one junior hire.
Medvi, in 60 seconds
Watch the founder short - and see the full profile on the Vibe Index.
Open the Medvi profile →The caveats
The figures are the company's, relayed by reporters, and the business sits in the most scrutinised corner of consumer health: compounded GLP-1s, subscription billing and aggressive performance marketing. Coverage since the NYT piece has raised questions - including a reported vulnerability around patient-data access and the regulatory pressure on compounded semaglutide - that a two-person team is not obviously built to absorb. Read the growth as real and the risk as real too.
What it signals
The vibe economy's thesis has always been that the tools collapse the team you need. Medvi is the version of that thesis with nine figures attached and no software product at all - the AI is in the operations, not the app. If you are a solo founder, the lesson is not "sell GLP-1s". It is that distribution plus automation now scales further with two people than it once did with two hundred, and that the compliance and trust layer is where the humans still have to be.
Read the newsletter that top founders & VCs keep in their inbox.